Scott Gibson

Scott Gibson is a seasoned professional in chemical development and pharmaceutical manufacturing with extensive experience spanning over two decades. Currently serving as Chemical Development Manager at Indivior since November 2023, Gibson previously held the position of Director of Drug Substance at Eliem Therapeutics, where responsibilities included overseeing drug substance development and managing contract manufacturing organizations. Notable roles include Principal Scientist at Smith & Nephew, leading technical consultancy for drug/device combination products, and Technical Transfer Lead at Novartis, managing product introductions like Kisqali® and Votrient®. Gibson's early career involved key positions at SAFC and GlaxoWellcome, contributing to process development and manufacturing support. Academically, Gibson holds an Executive MBA from the University of Hull and a PhD in Chemistry from the University of St Andrews.